National Library of Medicine; Notice of Meetings, 12195-12196 [2021-04225]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: February 24, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04299 Filed 3–1–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Martin Delaney
Collaboratories for HIV Cure Research (UM1
Clinical Trial Not Allowed); Martin Delaney
Collaboratory for Pediatric HIV Cure
Research (UM1 Clinical Trial Not Allowed)
Date: March 30–31, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: J. Bruce Sundstrom, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11A Rockville, MD
20852, 240–669–5045, sundstromj@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
17:11 Mar 01, 2021
Jkt 253001
Dated: February 24, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–04297 Filed 3–1–21; 8:45 am]
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
12195
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required)
Date: April 22–23, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13B,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health 5601 Fishers
Lane, Room 3G13B Rockville, MD 20852
(240) 669–5048 yong.gao@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 24, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04300 Filed 3–1–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; BRAIN Biology and
Biophysics of Neural Stimulations and
Recording Technologies.
Date: March 23, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Mirela Milescu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20852,
mirela.milescu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: February 24, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04298 Filed 3–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Library of
E:\FR\FM\02MRN1.SGM
02MRN1
12196
Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
Medicine Board of Scientific
Counselors.
The meeting will be open to the
public as indicated below. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for review, discussion, and evaluation of
individual intramural programs and
projects conducted by the NATIONAL
LIBRARY OF MEDICINE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Board of Scientific Counselors.
Date: April 22, 2021.
Open: April 22, 2021, 11:00 a.m. to 12:30
p.m.
Agenda: Program Discussion and Senior
Investigator Report.
Place: Virtual Meeting.
Closed: April 22, 2021, 12:30 p.m. to 12:45
p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: April 22, 2021, 12:45 p.m. to 3:45
p.m.
Agenda: Senior Investigator Report.
Closed: April 22, 2021, 3:45 p.m. to 4:15
p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Contact Person: Valerie Florance, Ph.D.,
Acting Scientific Director, National Library of
Medicine, National Institutes of Health, 6705
Rockledge Drive, Suite 500, Bethesda, MD
20892, 301–496–6221, floranc@mail.nih.gov.
Any member of the public may submit
written comments no later than 15 days after
the meeting. Any interested person may file
written comments with the committee by
forwarding the statement to the Contact
Person listed on this notice. The statement
should include the name, address, telephone
number and when applicable, the business or
professional affiliation of the interested
person.
Open sessions of this meeting will be
broadcast to the public, and available for
viewing at https://videocast.nih.gov on April
22, 2021. Please direct any questions to the
Contact Person listed on this notice.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
VerDate Sep<11>2014
17:11 Mar 01, 2021
Jkt 253001
Dated: February 24, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04225 Filed 3–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Cognitive and Neuropathological
signatures of Alzheimer’s Disease, Brain
Injury and Aging.
Date: March 23, 2021.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Fogarty Global Brain Disorders.
Date: March 23–24, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846 Bethesda, MD 20892 301–435–
1259 nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Member
Conflict: Child Psychopathology,
Developmental Disabilities, and Mechanisms
of Anxiety and Depression.
Date: March 25, 2021.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848 Bethesda, MD
20892, (301) 402–4411 tianbi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Antiviral Therapeutics.
Date: March 29–30, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Bethesda, MD
20894 301–435–4057 bidyottam.mittra@
nih.gov
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Dermatology Development and
Disease.
Date: March 29, 2021.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814 Bethesda, MD 20892, (301) 496–
8551 ingrahamrh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 24, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04229 Filed 3–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
The meeting will be held as a virtual
meeting and is open to the public.
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 86, Number 39 (Tuesday, March 2, 2021)]
[Notices]
[Pages 12195-12196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04225]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Library of
[[Page 12196]]
Medicine Board of Scientific Counselors.
The meeting will be open to the public as indicated below.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations should
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for review, discussion, and evaluation of individual
intramural programs and projects conducted by the NATIONAL LIBRARY OF
MEDICINE, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Library of Medicine Board of
Scientific Counselors.
Date: April 22, 2021.
Open: April 22, 2021, 11:00 a.m. to 12:30 p.m.
Agenda: Program Discussion and Senior Investigator Report.
Place: Virtual Meeting.
Closed: April 22, 2021, 12:30 p.m. to 12:45 p.m.
Agenda: To review and evaluate personal qualifications,
performance, and competence of individual investigators.
Open: April 22, 2021, 12:45 p.m. to 3:45 p.m.
Agenda: Senior Investigator Report.
Closed: April 22, 2021, 3:45 p.m. to 4:15 p.m.
Agenda: To review and evaluate personal qualifications,
performance, and competence of individual investigators.
Contact Person: Valerie Florance, Ph.D., Acting Scientific
Director, National Library of Medicine, National Institutes of
Health, 6705 Rockledge Drive, Suite 500, Bethesda, MD 20892, 301-
496-6221, [email protected].
Any member of the public may submit written comments no later
than 15 days after the meeting. Any interested person may file
written comments with the committee by forwarding the statement to
the Contact Person listed on this notice. The statement should
include the name, address, telephone number and when applicable, the
business or professional affiliation of the interested person.
Open sessions of this meeting will be broadcast to the public,
and available for viewing at https://videocast.nih.gov on April 22,
2021. Please direct any questions to the Contact Person listed on
this notice.
(Catalogue of Federal Domestic Assistance Program No. 93.879,
Medical Library Assistance, National Institutes of Health, HHS)
Dated: February 24, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04225 Filed 3-1-21; 8:45 am]
BILLING CODE 4140-01-P
